Bio-Techne Corp. TECH
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Bio-Techne Corp. (TECH) Core Market Data and Business Metrics
Latest Closing Price
$57.35Price-Earnings Ratio
60.37Total Outstanding Shares
158.09 Million SharesDividend
$0.08 Per Share QuarterlySIC Description
Biological Products, (no Disgnostic Substances)Primary Exchange
NASDAQHeadquarters
614 Mckinley Pl N E, Minneapolis, MN, 55413
Historical Stock Splits
If you bought 1 share of TECH before November 30, 2022, you'd have 4 shares today.
Execution Date | Split Amount |
---|---|
November 30, 2022 | 4-for-1 |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
---|---|---|---|
2,397,191 Shares | 2.61 | 3/14/2025 | 6,265,697 Shares |
1,662,592 Shares | 3.17 | 2/28/2025 | 5,269,076 Shares |
1,907,771 Shares | 2.66 | 2/14/2025 | 5,076,499 Shares |
1,047,329 Shares | 3.77 | 1/31/2025 | 3,948,474 Shares |
818,917 Shares | 4.95 | 1/15/2025 | 4,051,390 Shares |
696,292 Shares | 5.42 | 12/31/2024 | 3,774,113 Shares |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Financing Activities, Continuing | $-205.48 Million |
Net Cash Flow | $27.40 Million |
Net Cash Flow From Financing Activities | $-205.48 Million |
Net Cash Flow From Operating Activities | $303.49 Million |
Net Cash Flow, Continuing | $27.40 Million |
Net Cash Flow From Operating Activities, Continuing | $303.49 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Gross Profit | $767.55 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $40,000 |
Benefits Costs and Expenses | $995.28 Million |
Preferred Stock Dividends And Other Adjustments | $20,000 |
Nonoperating Income/Loss | $-14.51 Million |
Net Income/Loss Attributable To Parent | $150.71 Million |
Comprehensive Income
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Other Comprehensive Income/Loss | $17.93 Million |
Comprehensive Income/Loss Attributable To Parent | $168.64 Million |
Comprehensive Income/Loss | $154.29 Million |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Equity Attributable To Parent | $2.14 Billion |
Current Liabilities | $142.13 Million |
Other Non-current Assets | $1.35 Billion |
Noncurrent Liabilities | $455.24 Million |
Noncurrent Assets | $2.09 Billion |
Wages | $41.98 Million |
Historical Dividends
Current dividend: $0.08 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Feb 5, 2025 | Feb 28, 2025 | Feb 17, 2025 | $0.08 | Quarterly |
Oct 30, 2024 | Nov 22, 2024 | Nov 11, 2024 | $0.08 | Quarterly |
Aug 7, 2024 | Aug 30, 2024 | Aug 19, 2024 | $0.08 | Quarterly |
May 1, 2024 | May 24, 2024 | May 13, 2024 | $0.08 | Quarterly |
Feb 1, 2024 | Feb 26, 2024 | Feb 12, 2024 | $0.08 | Quarterly |
Oct 31, 2023 | Nov 24, 2023 | Nov 10, 2023 | $0.08 | Quarterly |